ArticleNuclear medicine communications2026

Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer.

Maryam Oroujeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.